Qube Research & Technologies »

C4 Therapeutics shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2M 388k 8.17
2023-09-30 $13k 6.9k 1.86
2023-06-30 $211k 77k 2.75
2023-03-31 $93k 30k 3.14

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Johnson & Johnson Call Option (JNJ)
Oracle Corporation (ORCL)
Tesla Motors Call Option (TSLA)
Hess (HES)
McDonald's Corporation Put Option (MCD)
Amgen Call Option (AMGN)
S&p Global Call Option (SPGI)

View all positions for Qube Research & Technologies

Top funds holding C4 Therapeutics

State Street Corporation
RA Capital Management
Daniel D. Thurber
Lynx1 Capital Management
Commodore Capital
Vanguard Group
Soleus Capital Management
Balyasny Asset Management
T. Rowe Price Associates
Bank of America Corporation
Silverarc Capital Management
Two Sigma Advisers
Arrowpoint Asset Management
Goldman Sachs Group
TCG Crossover Management

View all funds holding C4 Therapeutics